While the participants took study treatment, the participants in Group 1:
- had 2 phone calls and 2 visits with the study doctors
- stayed overnight at their study site for 2 nights and took their study treatment there

The participants in Group 2:
- took rabeprazole at home for 2 days
- had 2 phone calls and 2 visits with the study doctors
- stayed overnight at their study site for 2 nights and took their final dose of rabeprazole and their only dose of acalabrutinib there
- kept a diary of taking rabeprazole

About 10 days after the participants took their last study treatment, they visited their study site 1 time. At this visit, the study doctors checked the health of the participants.

The COVID-19 pandemic did not affect the way the study was done, the results of the study, or the conclusions of the researchers.

What were the results of this study?
This is a summary of the main results from this study overall. The results each participant had might be different and are not in this summary.

Researchers look at the results of many studies to decide which treatments work best and are safest. Other studies may provide new information or different results. Always talk to a doctor before making any treatment changes.

There were 2 out of the 37 participants who did not take any study treatment. So, the results below are for 35 of the 37 participants.

The websites listed at the end of this summary may have a full report of the study results.